Ph3 study of Rina-S versus treatment of investigator choice with ovarian cancer

Phase III Clinical Trial

A Phase 3 Randomized Open-label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Investigators Choice (IC) in Patients with Platinum Resistant Ovarian Cancer (GCT1184-02)

Indication: Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer, Ovarian Cancer
Trial Number: 06619236
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations